Adial Pharmaceuticals Ownership | Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals Ownership Summary

Adial Pharmaceuticals is owned by 2.48% institutional investors, 2.08% insiders, and 95.44% retail investors. Vanguard group is the largest institutional shareholder, holding 0.70% of ADIL shares. Fidelity Extended Market Index is the top mutual fund, with 0.48% of its assets in Adial Pharmaceuticals shares.

ADIL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Adial Pharmaceuticals	2.48%	2.08%	95.44%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	156.02K	0.70%	$34.33K
Geode capital management	155.75K	0.70%	$34.26K
Jane street group	121.84K	0.55%	$26.80K
Manchester capital management	48.10K	0.22%	$10.58K
Blackrock funding, inc. /de	27.77K	0.13%	$6.11M
Two sigma securities	12.84K	0.12%	$4.54K
Stonex group	19.45K	0.09%	$4.28K
Private management group	10.00K	0.05%	$2.20K
Ubs group	9.17K	0.04%	$2.02K
Tower research capital llc (trc)	1.37K	0.01%	$484.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Manchester capital management	48.10K	0.00%	$10.58K
Two sigma securities	12.84K	0.00%	$4.54K
Stonex group	19.45K	0.00%	$4.28K
Private management group	10.00K	0.00%	$2.20K
Two sigma investments, lp	-	-	-
Harbour investments	99.00	-	$22.00
Tower research capital llc (trc)	1.37K	-	$484.00
Ubs group	9.17K	-	$2.02K
1620 investment advisors	-	-	-
Virtu financial	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Jane street group	121.84K	-	109.50K
Stonex group	19.45K	0.00%	19.45K
Two sigma securities	12.84K	0.00%	12.84K
Harbour investments	99.00	-	99.00
Manchester capital management	48.10K	0.00%	-

Top Sellers

Holder	Shares	% Assets	Change
Virtu financial	-	-	-26.41K
Hrt financial lp	-	-	-11.19K
Two sigma investments, lp	-	-	-10.80K
Ubs group	9.17K	-	-9.59K
Geode capital management	155.75K	-	-8.38K

New Positions

Holder	Shares	% Assets	Change	Value
Stonex group	19.45K	0.00%	19.45K	$4.28K
Two sigma securities	12.84K	0.00%	12.84K	$4.54K
Harbour investments	99.00	-	99.00	$22.00

Sold Out

Holder	Change
Stone house investment management	-2.70K
1620 investment advisors	-3.60K
Citigroup	-3.97K
Two sigma investments, lp	-10.80K
Hrt financial lp	-11.19K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	13	-18.75%	549,548	-9.63%	2	32.95%	3	-62.50%	3	-
Sep 30, 2025	16	6.67%	608,084	159.09%	5	117.27%	9	28.57%	3	50.00%
Jun 30, 2025	16	23.08%	234,705	-1.48%	2	134.51%	7	16.67%	2	100.00%
Mar 31, 2025	1	-	3,600	-	-	508.75%	-	-100.00%	-	-
Dec 31, 2024	1	-	3,600	-	-	-	1	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	132.40K	0.48%	-
BlackRock Extended Equity Market K	17.57K	0.27%	-7.00
NT Ext Equity Mkt Idx Fd - L	65.41K	0.24%	64.81K
Spartan Extended Market Index Pool E	11.33K	0.17%	295.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 5	25.63K	0.09%	25.46K
Blackrock Extended Mkt Fund CF	20.16K	0.07%	20.16K
Extended Equity Market Fund K	17.29K	0.06%	11.00
Spartan Extended Market Index Pool F	12.00K	0.06%	281.00
Fidelity Series Total Market Index	9.16K	0.03%	-
Vanguard Institutional Extnd Mkt Idx Tr	9.04K	0.03%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 29, 2023	Schuyler Kevin	-	Buy	$1.92K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$27.10K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$13.60K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$26.60K
Nov 30, 2021	Stilley William B. III	Chief Executive Officer	Buy	$29.18K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q1	-	-
2023 Q3	1	-
2023 Q2	-	-
2022 Q4	-	-

ADIL Ownership FAQ

Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals shareholders are primarily institutional investors at 2.48%, followed by 2.08% insiders and 95.44% retail investors. The average institutional ownership in Adial Pharmaceuticals's industry, Biotech Stocks , is 382.13%, which Adial Pharmaceuticals falls below.

Who owns the most shares of Adial Pharmaceuticals?

Adial Pharmaceuticals’s largest shareholders are Vanguard group (156.02K shares, 0.70%), Geode capital management (155.74K shares, 0.70%), and Jane street group (121.84K shares, 0.55%). Together, they hold 1.96% of Adial Pharmaceuticals’s total shares outstanding.

Does Blackrock own Adial Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Adial Pharmaceuticals.

Who is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Manchester capital management is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 48.1K Adial Pharmaceuticals shares, valued at 10.58K$.

Who is the top mutual fund holder of Adial Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Adial Pharmaceuticals shares, with 0.48% of its total shares outstanding invested in 132.4K Adial Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools